Gene expression of the GATA-3 transcription factor is increased in atopic asthma

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 2 II, 1999, Pages 215-222

  Nakamura, Yutaka ^a   Ghaffar, Omar ^a   Olivenstein, Ronald ^a   Taha, Rame A ^a   Soussi Gounni, Abdelilah ^a   Zhang, Dong Hong ^b   Ray, Anuradha ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; eosinophils; GATA 3; IL 5; T lymphocytes

Indexed keywords

INTERLEUKIN 5; TRANSCRIPTION FACTOR;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION REGULATION; HUMAN; IN SITU HYBRIDIZATION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; ASTHMA; BRONCHI; DNA-BINDING PROTEINS; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-5; MALE; MIDDLE AGED; PHENOTYPE; RNA, MESSENGER; TRACHEA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0033049690     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70493-8     Document Type: Article

References (47)

1. McFadden ER Jr, Gillbert IA. Asthma. N Engl J Med 1992;327:1928-38.
2. Seminario MC, Gleich GJ. The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 1994;6:860-4.
3. James AL, Pare PD, Hogg JC. The mechanisms of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-6.
4. Calhoun WJ, Sedgwick J, Busse WW. The role of eosinophils in pathophysiology of asthma. Ann NY Acad Sci 1991;629:62-72.
5. Bentley AM, Menz G, Robinson DS, Bradley B, Jeffery PK, Durham SR, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa of intrinsic asthma: relationship to symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis 1992;145:500-6.
6. Watanabe A, Mishima H, Renzi PM, Xu LJ, Hamid Q, Martin JG. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. J Clin Invest 1995;96:1303-10.
7. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
8. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-7.
9. Bottomly K. Subsets of CD4 T cells and B cell activation. Semin Immunol 1989;1:21-31.
10. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL. Two types of murine helper T cell clone 1: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
12. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987;166:1229-44.
13. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
14. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IJ, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
15. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988;167:1737-42.
16. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989;73:1504-12.
17. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen specific immunoglobulins. J Clin Invest 1997;99:1329-39.
18. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-202.
19. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
20. Yasruel Z, Humbert M, Kotsimbos TC, Ploysongsang Y, Minshall E, Durham SR, et al. Membrane-bound and soluble αIL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthma. Am J Respir Crit Care Med 1997;155:1413-8.
21. Robinson DS, Hamid Q, Ying S, Bentley AM, Assoufi B, Durham SR, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
22. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for Th2-type (interleukin-4 and interleukin-5) and Th1-type (interleukin-2 and IFN-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
23. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
24. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 1989;339:64-7.
25. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin-5 and granulocyte/macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
26. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989;243:355-61.
27. Stranick KS, Payvandi F, Zambas DN, Umland SP, Egan RW, Billah MM. Transcription of the murine interleukin-5 gene is regulated by multiple promoter elements. J Biol Chem 1995;270:20575-82.
28. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997;272:21597-603.
29. Siegel MD, Zhang SH, Ray P, Ray A. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem 1995;270:24548-55.
30. Lee HJ, O'Garra A, Arai K, Arai N. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J Immunol 1998;160:2343-52.
31. Prieschl EE, Gouilleux-Gruart V, Walker C, Harrer NE, Baumruker T. A nuclear factor activated T cell-like transcription factor in mast cells is involved in IL-5 gene regulation after IgE plus antigen stimulation. J Immunol 1995;154:6112-9.
32. Zheng WP, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
33. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
34. Taha R, Kotsimbos ATC, Song Y-L, Menzies D, Hamid Q. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 1997;155:1135-9.
35. Hamid Q, Wharton J, Terenghi G, Hassall C, Aimi J, Taylor K, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in rat heart and human atrial appendage. Proc Natl Acad Sci USA 1987;84:6760-4.
36. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster IL-3, IL-4, IL-5, and GM-CSF in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
37. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, et al. T cells are the principle source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
38. Giaid A, Hamid Q, Adams C, Springall DR, Terenghi G, Polack JM. Non-isotopic RNA probes. Comparison between different labels and detection systems. Histochemistry 1989;93:191-6.
39. Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17-24.
40. Zon LI, Yamaguchi Y, Yee K, Albee EA, Kimura A, Bennett JC, et al. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 1993;81:3234-41.
41. Umland SP, Razac S, Shah H, Nahrebne DK, Egan RW, Billah MM. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-γ. Am J Respir Cell Mol Biol 1998;18:631-42.
42. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1994;91:752-6.
43. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, et al. Negative cross talk between Re1A and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 1995;9:401-12.
44. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 1995;15:943-53.
45. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. IκB α-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 1997;16:4698-707.
46. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-90.
47. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.